← Back to catalogue

Varex Imaging

FDA UDI

Class II (US FDA UDI)

by Varex Imaging Nederland B.V.

Identity

Trade Name
Varex Imaging FDA UDI
Generic Name
Manual-aperture-control diagnostic x-ray system collimator, non-motorized FDA UDI
Device Name
x-ray beam-limiting device, to restrict the dimensions of a diagnostic x-ray field by limiting the size of the primary x-ray beam.(Collimator) This is a device out of the Optica 10 series FDA UDI
Model / Reference
OPTICA10-01-017-001-OEM FDA UDI
Description
x-ray beam-limiting device, to restrict the dimensions of a diagnostic x-ray field by limiting the size of the primary x-ray beam.(Collimator) This is a device out of the Optica 10 series FDA UDI

Identifiers

Primary DI / UDI-DI
08718755003383 FDA UDI
FDA Product Code
IZX FDA UDI
GMDN Term
Manual-aperture-control diagnostic x-ray system collimator, non-motorized FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
892.1610 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

No

FDA UDI

Serial Number

Yes

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

Yes

FDA UDI

Category: Manual-aperture-control diagnostic x-ray system collimator, non-motorized

Varex Imaging by Varex Imaging Nederland B.V. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Manual-aperture-control diagnostic x-ray system collimator, non-motorized.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI a2647113-4ab2-4238-ba71-46864069a27f 33 fields · synced May 30, 2026